RxDoctor Payments Data

Ketan Patel, DPM

Foot & Ankle Surgery · Conyers, GANPI 1447254131

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $10,027 of the $13,702 with a category attached, or 73.2%. Fuse Medical, Inc. accounts for 73.2% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2023 at $4,483 and has fallen 88.6% since, to $509 in 2025.

$13,702in general payments, 2019–2025

Across 66 payments — averaging $207.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fuse Medical, Inc.$10K
  • Kerecis Limited$923
  • Amgen$570
  • Bioventus LLC$349
  • Flower Orthopedics Coporation$273
  • Medtronic$184
  • plus $1K from 24 others

What the payments were for

  • Royalty or licence$10,02773%
  • Food & beverage$3,67527%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,702 in reported general payments places this provider in the 85th percentile of 239 foot & ankle surgery providers in Georgia.

See all foot & ankle surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$150,966
Medicare patients
484
Services billed
2,062

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib210$5,601
Colchicine22$1,914
CiclopiroxCiclopirox Olamine41$971
Methylprednisolone42$218
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim36$156
Clindamycin Hcl14$107
Gabapentin12$102
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$77
Ibuprofen11$74

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Conyers

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →